Susquehanna International Group
ANAB icon

Susquehanna International Group’s AnaptysBio ANAB Stock Holding History

Susquehanna International Group’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$421K Sell
7,600
-31,100
-80% -$1.67M ﹤0.01% 10083
2025
Q4 		$1.88M Buy
38,700
+18,500
+92% +$721K ﹤0.01% 5798
2025
Q3 		$619K Sell
20,200
-119,900
-86% -$2.75M ﹤0.01% 8479
2025
Q2 		$3.11M Buy
140,100
+69,300
+98% +$1.45M ﹤0.01% 4886
2025
Q1 		$1.32M Sell
70,800
-222,900
-76% -$3.72M ﹤0.01% 6554
2024
Q4 		$3.89M Buy
293,700
+144,500
+97% +$3.5M ﹤0.01% 4001
2024
Q3 		$5M Buy
+149,200
New +$5.1M ﹤0.01% 3592
2023
Q2 		– Sell
-37,300
Closed -$812K – 11991
2023
Q1 		$812K Sell
37,300
-900
-2% -$21.9K ﹤0.01% 7371
2022
Q4 		$1.18M Sell
38,200
-30,800
-45% -$870K ﹤0.01% 5811
2022
Q3 		$1.76M Buy
69,000
+3,000
+5% +$70.3K ﹤0.01% 5192
2022
Q2 		$1.34M Buy
+66,000
New +$1.46M ﹤0.01% 5816
2022
Q1 		– Sell
-6,000
Closed -$209K – 12915
2021
Q4 		$209K Sell
6,000
-5,100
-46% -$162K ﹤0.01% 11347
2021
Q3 		$301K Buy
11,100
+100
+0.9% +$2.54K ﹤0.01% 10593
2021
Q2 		$285K Sell
11,000
-4,600
-29% -$110K ﹤0.01% 10871
2021
Q1 		$336K Buy
+15,600
New +$394K ﹤0.01% 10365
2020
Q3 		– Sell
-18,300
Closed -$409K – 10492
2020
Q2 		$409K Sell
18,300
-96,400
-84% -$1.76M ﹤0.01% 7782
2020
Q1 		$1.62M Sell
114,700
-17,200
-13% -$261K ﹤0.01% 4355
2019
Q4 		$2.14M Buy
131,900
+80,700
+158% +$1.91M ﹤0.01% 4214
2019
Q3 		$1.79M Sell
51,200
-25,100
-33% -$1.19M ﹤0.01% 4433
2019
Q2 		$4.3M Sell
76,300
-70,600
-48% -$5.08M ﹤0.01% 2916
2019
Q1 		$10.7M Sell
146,900
-28,300
-16% -$1.95M ﹤0.01% 1679
2018
Q4 		$11.2M Sell
175,200
-179,100
-51% -$13.3M ﹤0.01% 1512
2018
Q3 		$35.3M Buy
354,300
+330,500
+1,389% +$27.4M 0.01% 895
2018
Q2 		$1.69M Sell
23,800
-190,100
-89% -$15.9M ﹤0.01% 4312
2018
Q1 		$22.3M Buy
213,900
+151,000
+240% +$17M 0.01% 1143
2017
Q4 		$6.33M Buy
+62,900
New +$4.63M ﹤0.01% 2274

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group's ANAB Position: Q1 2026 in Review

Susquehanna International Group opened a new position in AnaptysBio (ANAB) in Q1 2026: 26,577 shares worth $1.47M. The stake represents ﹤0.01% of the portfolio and ranks #6926 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in ANAB as recently as Q3 2025.

Susquehanna International Group first reported a position in ANAB in Q4 2017 and has held it in 30 quarters since. The position peaked at $8.88M in Q1 2018. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Susquehanna International Group held 26,577 shares of AnaptysBio worth $1.47M as of Q1 2026.
  • AnaptysBio was a new Susquehanna International Group position in Q1 2026.
  • AnaptysBio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6926 holding.
  • Susquehanna International Group first reported a position in AnaptysBio in Q4 2017 and has held it in 30 quarters since.
  • Susquehanna International Group's AnaptysBio position peaked at $8.88M in Q1 2018.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.